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DOI: http://dx.doi.org/10.1016/j.hemonc.2015.03.001Hepatocellular carcinoma (HCC) is the sixth most common neoplasm worldwide; HCC metastasis is
common affecting 50% of cases. However, metastasis to the oral cavity is extremely infrequent. We pre-
sent a case of hepatocellular cancer first presenting as a mass lesion at the upper alveolus and review
metastatic hepatocellular carcinoma to the oral cavity in 73-year-old male patient.
KEYWORDS: Oral cavity; Hepatocellular carcinomaepatocellular carcinoma (HCC) is the sixthHmost common neoplasm worldwide, with748,000 new cases each year. Its very poor
prognosis makes it now the third leading cause of can-
cer mortality, responsible for 695,000 deaths annu-
ally.1 It has been recognized that HCC develops
within an established background of chronic liver dis-
ease in most cases. Hepatitis C (HCV), hepatitis B
(HBV), aﬂatoxin B1, and alcohol use are the major
etiological agents that lead to the development of
HCC.2 HCC metastasis is common and present in
50% of cases. The lungs, diaphragm, abdominal
lymph nodes, and bones are the most frequently
affected extrahepatic sites.3,4 However, metastasis to
the oral cavity is extremely infrequent and rarely
encountered.5 We report a case of hepatocellular car-
cinoma that ﬁrst presented as an oral cavity mass
lesion of the upper alveolar process of a 73-year-old
male patient. We also present a review of metastatic
hepatocellular carcinoma to the oral cavity.REPORT
A 73-year-old male patient with a past medical his-
tory of diabetes mellitus was referred to our hospitalwith a two-month history of an upper gingival, pain-
less mass lesion which gradually increased in size until
it protruded through the mouth opening and bled
occasionally, especially after eating. Almost simultane-
ously, the patient also experienced a signiﬁcant
decrease of appetite. The patient denied any history
of smoking, alcohol consumption or use of chewable
recreational material.
Examination of the oral cavity conﬁrmed the pres-
ence of a 4 · 5 cm exophytic non-tender mass lesion in
the upper middle alveolus extending posteriorly to the
hard palate and covered with blood clots (Figure 1).
His airway was clear and no other oral cavity or head
and neck abnormalities were identiﬁed. No lymph
nodes or other mass lesions were present during his
neck examination. The abdomen was somewhat
distended but no palpable mass lesions were detected
and a mild pitting edema of both legs was present.
The patient was admitted to our institution for
further management where he immediately received
nutritional support. His iodinated contrast computed
tomography (CT) scan of the head and neck con-
ﬁrmed the presence of a 2.7 · 5.1 · 4.3 cm soft tissue
mass lesion of the maxillary alveolar process that
bulged into the lingual and buccal surfaces of thearter 2015
Figure 2. CT head and neck (sagittal view) showing the alveolar mass.
Figure 1. Photograph of the lesion demonstrating exophytic mass, covered with blood clots, in the upper alveolus protruding through the mouth
opening and extending backward to involve the hard palate.
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Figure 3. (a) CT abdomen demonstrating moderate ascites and large tumor mass in the right lobe of the liver (9.6 · 9.8 · 11 cm). (b) CT chest
showing right pleural effusion and multiple bilateral metastatic lung nodules.
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cerebellar enhancing lesions consistent with brain
metastasis were also identiﬁed with his CT scan.
The patient’s CT scan of the chest revealed a right
pleural effusion, a pronounced mediastinal lym-
phadenopathy and a large number of lung metastases
(Figure 3). CT scan of the abdomen also demonstrated
moderate ascites and a large tumor mass in the right
lobe of the liver measuring 9.6 · 9.8 · 11 cm.(Figure 3). In addition, a malignant-appearing mass
lesion of the left kidney was identiﬁed.
Histopathological assessment of the oral lesion was
initially reported by the referring hospital as a ‘‘high
grade tumor’’. Further histopathological review per-
formed at our hospital demonstrated ﬁndings compat-
ible with metastatic high grade hepatocellular
carcinoma as the tumor cells were large with hepatoid
appearance, forming cords and trabeculae withHematol Oncol Stem Cell Ther 8(3) Third Quarter 2015
Figure 4. Hematoxylin and eosin section showing ulcerated surface above the tumor (a) and the trabecular sinusoidal growth pattern of the lesion
under high power field (b).
HEPATOCELLULAR CARCINOMA case reportsinusoidal pattern, and surrounded in some areas by
endothelial cells, as noticed on CD34 staining.
Tumor cells were negative for vimentin and AE1/
AE3 cytokeratin but strongly positive for alpha feto-
protein and low molecular weight cytokeratin 8/18.
CD10 also highlighted some of the canalicular
patterns seen in hepatocellular carcinoma (Figures 4
and 5). Hep-Par 1 immunostain demonstrated multi-
focal positivity (Figure 6).
Based on the above ﬁndings, serum alpha fetoprotein
was measured and found to be abnormally high
(16,901 lg/L). Hepatitis proﬁle showed a picture of
chronic hepatitis B infection. In light of these ﬁndings,
the diagnosis of hepatocellular carcinoma secondary to
chronic hepatitis B infection with multiple metastases
to the oral cavity, brain, lung, and kidneywas established.
At some point during his hospitalization, the patient
experienced severe bleeding from the oral lesion, which
was controlled by angioembolization. According to the
assessment by the medical oncology team, the patientHematol Oncol Stem Cell Ther 8(3) Third Quarter 2015was unﬁt for chemotherapy and was therefore referred
back to the local hospital for palliative care.DISCUSSION
This case is of special interest as the patient was
referred to our combined head and neck clinic with
an oral mass lesion from a region where squamous cell
carcinoma of the oral cavity is highly prevalent. The
initial biopsy report was suspicious for high grade
tumor and the patient was admitted with an impres-
sion of high grade oral cancer to be managed by our
Head and Neck Multidisciplinary Team. The radio-
logical workup revealed multiple malignant masses
involving the maxillary alveolus, the brain, the lung,
the liver, and the kidney, giving the impression of
an advanced oral cavity malignant tumor. Later on,
a further review of the biopsy at our histopathology
department led to the diagnosis of metastatic hepato-
cellular carcinoma to the oral cavity.133
Figure 5. Sections showing positive alpha-fetoprotein staining (a). CD10 stain highlighting some canalicular pattern (b). CD34 staining highlighting the endothelial cells
(sinusoidal pattern) (c). Low molecular weight CK8/18 positive staining (d).
Figure 6. Hep-Par 1 immunostain which demonstrates multifocal positivity.
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Extrahepatic metastasis of hepatocellular carci-
noma is relatively common. The lungs, abdominal
lymph nodes and bones are, in decreasing order of
incidence, the common sites of metastasis.3,4
Metastasis to the oral cavity and jaws is rare, but in
the event, the most common oral sites are the mand-
ible and the gingiva.5
A review of the PubMed literature through to
December 2012 using the search keys ‘‘metastasis’’,
‘‘gingiva’’, ‘‘mandible’’, and ‘‘hepatocellular carcinoma’’
yielded 80 reported cases of metastatic hepatocellular
carcinoma to the oral cavity and the jaw region. Of
these 80 cases, 17 involved the gingiva.
Pires et al. reported a case of hepatocellular carci-
noma metastasis to the anterior mandibular gingiva.
In their review, 61 cases of hepatocellular carcinoma
metastasis to the oral cavity region were found. Of
these 61 cases, seven were in the maxillary gingiva,
one in the anterior maxilla, two in maxillary sinus,
and three involved both mandible and maxilla.5
Ramirez et al. reported a case of isolated gingival
metastasis from hepatocellular carcinoma. In their
review, they found 10 reported cases of gingival
metastasis in the literature through to 2003.6
However, up to 8% of all oral malignancies and
about 1% of jaw tumors represent metastatic cancer.8
For men, the most commonly reported primary sites
are the lung, kidney, liver, and prostate; while for
females, breast, genital organs, kidney, and colorectum
are the most commonly reported primary sites.7
A retrospective study by Seoane et al. on 39
patients with oral metastatic tumors between 1978
and 2007 found gingival metastases in 63% of oral soft
tissue metastasis and the primary tumors were located
in the lung, liver, and breast. The mean age was
65.2 years. In this series, two out of seven patientsHematol Oncol Stem Cell Ther 8(3) Third Quarter 2015presented with gingival metastasis from primary hep-
atocellular carcinoma and both of them were in the
upper gingiva.8
Analysis of 673 cases of metastatic tumors to the
oral cavity by Hirshberg et al. demonstrates that
23% of the cases were the ﬁrst indication of undiscov-
ered primary neoplasms. Jaw bones, particularly the
mandible, were affected more frequently than oral soft
tissues. The gingiva was the most frequently affected
oral soft tissue. Lung, kidney, liver, and prostate were
the most common primary sites for men while in
women breast, female genital organs, kidney, and col-
orectum were the most common primary sites.9
The prognosis of patients with metastatic hepato-
cellular carcinoma is poor. The cumulative survival
rates at one year, two years, three years, and ﬁve years
after the diagnosis of extrahepatic in a cohort of 342
by Uchino et al. were 39.3%, 15.3%, 7.4%, and 4%,
respectively. With treatment of extrahepatic metasta-
sis, the rates at one year, two years, and three years
were 48.9%, 21.2%, and 10.6%, respectively. These
rates fell to 19%, 2.3%, and 0%, respectively, when
no treatment was administered.10CONCLUSIONS
Malignant lesions of the oral cavity are not always pri-
mary lesions originating in the cavity itself but could
sometimes bemetastatic lesions of a distant undisclosed
primary site. Thorough clinical, radiological and
histopathological evaluations are key factors in deter-
mining the diagnosis and management of such lesions.CONFLICTS OF INTEREST
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